Cardiac magnetic resonance imaging and management of dilated cardiomyopathy in a Duchenne muscular dystrophy manifesting carrier.
Barison
A
A
Aquaro
G D
GD
Passino
C
C
Falorni
M
M
Balbarini
A
A
Lombardi
M
M
Pasquali
L
L
Emdin
M
M
Siciliano
G
G
D000328:Adult; D015415:Biomarkers / Q000032:analysis / Q000097:blood; D002227:Carbazoles / Q000627:therapeutic use; D002311:Cardiomyopathy, Dilated / Q000235:genetics* / Q000473:pathology* / Q000628:therapy; D000077261:Carvedilol; D002648:Child; D003402:Creatine Kinase / Q000032:analysis / Q000097:blood; D004252:DNA Mutational Analysis; D018450:Disease Progression; D016189:Dystrophin / Q000172:deficiency / Q000235:genetics; D004452:Echocardiography; D015444:Exercise; D005260:Female; D006329:Heart Conduction System / Q000503:physiopathology / Q000601:surgery; D006352:Heart Ventricles / Q000000981:diagnostic imaging / Q000473:pathology* / Q000503:physiopathology; D006579:Heterozygote; D006801:Humans; D018482:Muscle, Skeletal / Q000378:metabolism / Q000473:pathology / Q000503:physiopathology; D020388:Muscular Dystrophy, Duchenne / Q000150:complications* / Q000235:genetics*; D009154:Mutation / Q000235:genetics; D009206:Myocardium / Q000378:metabolism / Q000473:pathology; D011412:Propanolamines / Q000627:therapeutic use; D013148:Spironolactone / Q000627:therapeutic use; D013610:Tachycardia / Q000209:etiology / Q000503:physiopathology / Q000601:surgery; D016896:Treatment Outcome
D015415:Biomarkers; D002227:Carbazoles; D016189:Dystrophin; D011412:Propanolamines; D000077261:Carvedilol; D013148:Spironolactone; D003402:Creatine Kinase